- Home
- LOAN vs CNTB Comparison
LOAN vs CNTB Comparison
Compare LOAN & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOAN
- CNTB
- Stock Information
- Founded
- LOAN 1989
- CNTB 2012
- Country
- LOAN United States
- CNTB United States
- Employees
- LOAN N/A
- CNTB N/A
- Industry
- LOAN Real Estate Investment Trusts
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- LOAN Real Estate
- CNTB Health Care
- Exchange
- LOAN Nasdaq
- CNTB Nasdaq
- Market Cap
- LOAN 61.4M
- CNTB 53.9M
- IPO Year
- LOAN 1999
- CNTB 2021
- Fundamental
- Price
- LOAN $5.67
- CNTB $1.05
- Analyst Decision
- LOAN
- CNTB Strong Buy
- Analyst Count
- LOAN 0
- CNTB 1
- Target Price
- LOAN N/A
- CNTB $8.00
- AVG Volume (30 Days)
- LOAN 20.8K
- CNTB 28.0K
- Earning Date
- LOAN 03-10-2025
- CNTB 09-05-2024
- Dividend Yield
- LOAN 8.11%
- CNTB N/A
- EPS Growth
- LOAN 6.53
- CNTB N/A
- EPS
- LOAN 0.49
- CNTB N/A
- Revenue
- LOAN $7,394,068.00
- CNTB $24,116,000.00
- Revenue This Year
- LOAN N/A
- CNTB N/A
- Revenue Next Year
- LOAN N/A
- CNTB $63.90
- P/E Ratio
- LOAN $11.57
- CNTB N/A
- Revenue Growth
- LOAN 5.79
- CNTB N/A
- 52 Week Low
- LOAN $4.60
- CNTB $0.90
- 52 Week High
- LOAN $5.90
- CNTB $2.66
- Technical
- Relative Strength Index (RSI)
- LOAN 57.76
- CNTB 45.74
- Support Level
- LOAN $5.30
- CNTB $1.01
- Resistance Level
- LOAN $5.70
- CNTB $1.40
- Average True Range (ATR)
- LOAN 0.12
- CNTB 0.13
- MACD
- LOAN 0.00
- CNTB -0.01
- Stochastic Oscillator
- LOAN 74.00
- CNTB 25.53
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.